ARCHIVES

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

This article is from The Cancer Letter archive.

Vol. 08 No. 43 | November 5, 1982

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

Hammer to Produce US-USSR “Cancer Summit” March 29

March 25, 1988

NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access

November 1, 1996

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

Drug Shortages Prompt Doctors, Societies to Consider Non-Profit Pharma Company

September 9, 2011